BBIO
BBIO
US10806X1028
BridgeBio Pharma, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
12.78B EUR
14.54B EUR
14.53B EUR
14.9B EUR
Enterprise Value
15.38B EUR
16.36B EUR
16.15B EUR
16.19B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
2,261.25x
--
--
--
Price to Sales
17.92x
20.4x
25.06x
38.65x
Price to Book
--
--
--
--
EV/Revenue
21.56x
22.94x
27.84x
42x
EV/EBITDA
-32.53x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-2.51%
-3.01%
-3.11%
-1.71%
ende